EdgarLookup
NT 10-Q

FORM 12B-25

Company
Eloxx Pharmaceuticals, Inc.
Filed
May 18, 1999
Period of Report
March 31, 1999
Accession Number
0001015357-99-000082
View on SEC.gov ↗